Vertex Pharmaceuticals Inc (VRTX)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	US$ in thousands	22,533,200	22,240,200	20,132,100	23,917,400	22,730,200	21,726,200	20,349,200	18,974,200	18,150,900	16,706,400	15,582,200	14,256,100	13,432,500	12,618,700	12,221,700	12,115,100	11,751,800	11,301,600	10,216,400	8,893,200
Debt-to-assets ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $22,533,200K
= 0.00

The debt-to-assets ratio for Vertex Pharmaceuticals Inc has consistently been 0.00 for all reported periods from March 31, 2020, to December 31, 2024. This indicates that the company has not used debt as a source of financing to acquire assets during these periods. A debt-to-assets ratio of 0.00 implies that the company's assets are entirely financed by equity, suggesting a low financial risk in terms of debt obligations and interest payments. It also indicates financial stability and a strong balance sheet position, as the company is not relying on debt to support its operations or growth. Overall, Vertex Pharmaceuticals Inc's consistent 0.00 debt-to-assets ratio reflects a prudent financial strategy focused on maintaining a healthy capital structure.